Herpes simplex virus partially liquifies the tightly packed, gel-like interior of human cell nuclei to copy itself faster, a new study shows.

Gene and cell therapy is moving fast – and in a clear direction. Programs are pushing toward more complex payloads, virus-free engineering, and manufacturing models that can scale from early research ...

Herpes simplex virus partially liquefies the tightly packed, gel-like interior of human cell nuclei to copy itself faster, a new study shows. The research centers on how the nucleus of each human cell ...

Researchers from Indian Institute of Science Education and Research (IISER) Mohali have discovered that unique antibodies ...

Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® ...

CDI-988 is a direct-acting, oral antiviral being developed for norovirusNorovirus challenge study is underway at Emory University School of Medicine to evaluate efficacy and safety of CDI-988 No ...

The South Korean vaccine manufacturer obtained financial backing from the RIGHT Foundation to advance respiratory syncytial ...

Scientists uncover how Tuberculosis (TB) bacteria uses fats for energy, mapping a key protein and opening new paths for drug ...

SK bioscience announced on 18 that it has entered into a funding agreement with the Research Investment for Global Health ...

On March 20, 2026, Hachette Book Group confirmed it would not publish the American edition of Shy Girl by Mia Ballard, and ...

Discover the proven viral clip translation method that's helping creators explode their growth. Learn exactly how to f ...

Discovered in 1964 by Anthony Epstein, Yvonne Barr, and Bert Achong, the Epstein-Barr virus (EBV) has intrigued tumor virologists due to its unique behavior. Typically, EBV establishes a lifelong, ...